<DOC>
	<DOCNO>NCT00743639</DOCNO>
	<brief_summary>This study describe control randomized clinical trial evaluate efficacy bone marrow derive stem-cell implant minithoracotomy patient dilate cardiomyopathy cardiac failure class III NYHA .</brief_summary>
	<brief_title>Autologous Transplantation Bone Marrow Mononuclear Stem-Cells Dilated Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Diagnosis make one year symptomatic functional class IIIIV New York Heart Association classification ( NYHA ) despite optimal pharmacologic therapy Left ventricular ejection fraction ( LVEF ) less 35 % echocardiogram Age 70 year Absence neoplasm Abscence hematologic disease systemic disease No previous cardiac intervention Episodes tachycardia ventricular fibrillation Severe moderate mitral insufficiency Any valvulopathies Previous cardiac surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Cardiomyopathy</keyword>
	<keyword>stem cell</keyword>
	<keyword>cardiac failure</keyword>
</DOC>